The Cooper Companies, Inc.
COO
Clasificación en acciones
#1933
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Precio por acción
$57.50
Última sincronización: 2026-10-16
Capitalización bursátil
$10.93B
Cambio (1 día)
0.17%
Cambio (1 año)
-20.11%
País
US
Comercio The Cooper Companies, Inc. (COO)
Categoría
Healthcare
EPS de The Cooper Companies, Inc. (COO)
EPS a fecha de July 2026 TTM: $2.93
Según los últimos informes financieros y el precio de las acciones de The Cooper Companies, Inc., el EPS actual de la empresa (TTM) es $2.93. Al final del año 2024, la empresa tenía un EPS de $1.97 un aumento con respecto a al EPS de 2023, que fue de $1.49.
Historial de EPS de The Cooper Companies, Inc. desde 2000 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2026 (TTM) | $2.93 | 55.85% |
| 2025 | $1.88 | -4.57% |
| 2024 | $1.97 | 32.21% |
| 2023 | $1.49 | -23.98% |
| 2022 | $1.96 | -96.72% |
| 2021 | $59.73 | 1,129.01% |
| 2020 | $4.86 | -48.68% |
| 2019 | $9.47 | 232.28% |
| 2018 | $2.85 | -62.65% |
| 2017 | $7.63 | 35.04% |
| 2016 | $5.65 | 34.52% |
| 2015 | $4.20 | -25.13% |
| 2014 | $5.61 | -7.88% |
| 2013 | $6.09 | 17.57% |
| 2012 | $5.18 | 38.50% |
| 2011 | $3.74 | 50.81% |
| 2010 | $2.48 | 11.21% |
| 2009 | $2.23 | 52.74% |
| 2008 | $1.46 | -684.00% |
| 2007 | $-0.25 | -116.78% |
| 2006 | $1.49 | -27.67% |
| 2005 | $2.06 | -27.21% |
| 2004 | $2.83 | 28.64% |
| 2003 | $2.20 | 37.50% |
| 2002 | $1.60 | 28.00% |
| 2001 | $1.25 | 22.55% |
| 2000 | $1.02 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| $8.85 | 202.05% |
US
|
|
| $6.41 | 118.61% |
FR
|
|
| - | - |
JP
|
|
| $3.32 | 13.31% |
US
|
|
| - | - |
CH
|
